{
    "Trade/Device Name(s)": [
        "Bio-Rad VARIANT\u2122nbs Sickle Cell Program",
        "Bio-Rad VARIANTnbs Sickle Cell Program"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K051072",
    "Predicate Device Reference 510(k) Number(s)": [
        "K924813"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKA"
    ],
    "Summary Letter Date": "May 12, 2005",
    "Summary Letter Received Date": "April 26, 2005",
    "Submission Date": "April 19, 2005",
    "Regulation Number(s)": [
        "21 CFR 864.7415"
    ],
    "Regulation Name(s)": [
        "Abnormal hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin F",
        "Hemoglobin A",
        "Hemoglobin S",
        "Hemoglobin D",
        "Hemoglobin C",
        "Hemoglobin E"
    ],
    "Specimen Type(s)": [
        "Neonatal dried blood spot"
    ],
    "Specimen Container(s)": [
        "Filter paper collection card",
        "Plastic 96 microwell plate"
    ],
    "Instrument(s)/Platform(s)": [
        "Bio-Rad VARIANTnbs Newborn Screening System",
        "VARIANTnbs Neonatal Auto Sampler",
        "VARIANTnbs Neonatal Chromatography Station",
        "Genetic Data Management (GDM) Software"
    ],
    "Method(s)/Technology(ies)": [
        "High performance liquid chromatography (HPLC)",
        "Cation exchange chromatography",
        "Dual-wavelength filter photometer"
    ],
    "Methodologies": [
        "Abnormal hemoglobin quantitation",
        "Qualitative screening"
    ],
    "Submission Type(s)": [
        "Reagent kit",
        "Analyzer",
        "Instrument",
        "Software",
        "Accessory",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad VARIANTnbs Sickle Cell Program for qualitative screening of hemoglobins F, A, S, D, C, and E in neonatal dried blood spot specimens using HPLC on the VARIANTnbs Newborn Screening System",
    "Indications for Use Summary": "Intended as a qualitative screen for the presence of hemoglobins F, A, S, D, C and E in eluates of neonatal blood collected on filter paper by high performance liquid chromatography (HPLC), for professional in vitro diagnostic use with the VARIANTnbs Newborn Screening System.",
    "fda_folder": "Hematology"
}